Flamel and Theralpha partnered to co-develop a controlled-release formulation of THA902 for pain

Flamel Technologies S.A.

France / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Theralpha S.A.S.

France / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced